JPMorgan Starts Akoustis Technologies (AKTS) at Overweight

February 3, 2026 2:29 AM EST Send to a Friend
JPMorgan analyst Jessica Fye initiates coverage on Akoustis Technologies (NASDAQ: AKTS) with a Overweight rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login